Search Results

You searched for : HSCT

	Startups that make life of Thalassemia patients easier â€“ Special Feature on World Thalassemia Day - 8th May Thalassemia is a preventable genetic blood disorder in which the patient's body cannot make sufficient red blood cells (RBC) on its own and require ... May 07
	Lupin Launches Posaconazole Delayed-Release Tablets Lupin & its AET Pharma US Inc. (part of Tiefenbacher Group) received an approval for its ANDA from the USFDA... Feb 17
	First Clinical Data from Ongoing Orca-T Trial Shows Significantly Improved 12-Month Graft Versus Host Disease (GvHD)-Free and Relapse-Free Survival (GRFS) in Blood Cancer Patients Receiving a Hematopoietic Stem Cell Transplant (HSCT) Orca Bio, today announced the first clinical data from its first-generation investigational therapy,... Dec 07
	New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint Takeda Pharmaceutical Company Limited today announced top-line results from the Phase 3 clinical trial evaluating the efficacy and safety of the investigational drug TAK-... Dec 04
	Merck received US FDA approval for Keytruda FDA approves expanded indication for Merckâ€™s KEYTRUDA (pembrolizumab) in adult patients with relapsed or refractory classical hodgkin lymphoma (cHL) ... Oct 16
	FDA Approves Expanded Indication for Merckâ€™s KEYTRUDA in Adult Patients With classical Hodgkin Lymphoma (cHL) ... Oct 15
	Stem Cell therapy has long lasting Neurological benefits Researchers show that stem cell therapy has a better and long-lasting effect on Neurological disorders.... Mar 19
7 Matching result(s) found!

-Advertisements-

Trending Now
	Dish TV Revolutionizes Entertainment with ‘Dish TV Smart+’ Services, Offering TV and OTT on Any Screen, AnywhereApril 26, 2024
	Arohan Financial Services Recognized Among India's Best Workplaces in BFSI 2024April 26, 2024
	Why Podcasts Are the Next Big Thing in Healthcare Advertising in IndiaApril 26, 2024
	Challenges of Child Growth at High Altitudes: New Study Reveals ImpactApril 26, 2024
	Staying Cool in India's Scorching Heat: Heatwave Safety TipsApril 26, 2024
	The Dark Side of Neotame (Artificial Sweetener): New Research Raises Concerns about Gut HealthApril 26, 2024
	Sightsavers India Fellowship Program Invites Applications for Promising OphthalmologistsApril 25, 2024
	Transforming Brain Healthcare: India's Visionary Task Force for Neurological DisordersApril 25, 2024
	The Battle Against Malaria: Rising Trends and Vaccine InnovationsApril 25, 2024
	Talc and Asbestos Controversy: Inside Johnson & Johnson's Courtroom StruggleApril 25, 2024
	The Hidden Struggles of Parenthood: Addressing Isolation, Loneliness, and BurnoutApril 25, 2024
	FDA Confirms Bird Flu Virus Remnants in Pasteurized Milk: Safety and Regulatory InsightsApril 24, 2024
	Sarvodaya Hospital Redefines Total Knee Replacement Surgery with Augmented Reality April 23, 2024
	Fateh Education announces partnership to expand educational opportunities for Indian studentsApril 23, 2024
	10 Strategies to counter disinformation for the healthcare digital ecosystemApril 23, 2024
	Is Selling Over-the-Counter (OTC) Drugs in General Stores A Step Towards Affordable Healthcare in IndiaApril 23, 2024
	Student Health Crisis: Food Poisoning Incident Strikes Pune Coaching CentreApril 23, 2024
	The Impact of Diabetes on Kidney Health: Diabetic Nephropathy ExplainedApril 23, 2024
	Toddler Hospitalized After Consuming Expired Chocolates: Health Concerns RaisedApril 23, 2024
	After months of diagnostic delay, a migrant worker could access TB services only when a community health worker met himApril 22, 2024

Search Results

Startups that make life of Thalassemia patients easier â€“ Special Feature on World Thalassemia Day - 8th May

Lupin Launches Posaconazole Delayed-Release Tablets

First Clinical Data from Ongoing Orca-T Trial Shows Significantly Improved 12-Month Graft Versus Host Disease (GvHD)-Free and Relapse-Free Survival (GRFS) in Blood Cancer Patients Receiving a Hematopoietic Stem Cell Transplant (HSCT)

New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint

Merck received US FDA approval for Keytruda

FDA Approves Expanded Indication for Merckâ€™s KEYTRUDA in Adult Patients With classical Hodgkin Lymphoma (cHL)

Stem Cell therapy has long lasting Neurological benefits

Trending Now